Signaling Pathways - NUAK1 - Urokinases - Insulin and Insulin-like Receptors - BMI-1
清除全部
-
B1374 WZ4003Target: NUAK1|NUAK2Summary: NUAK1/2抑制剂 -
B2268 Amiloride HCl dihydrate中文名: 盐酸阿米洛利二水合物Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|UrokinasesSummary: 有效上皮钠通道（ENaC）阻断剂 -
B3179 PTC-209Target: BMI-1Summary: Bmi-1抑制剂 -
A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂 -
A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂 -
A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂 -
A4445 4-Chlorophenylguanidine hydrochlorideTarget: UrokinasesSummary: 尿激酶（urokinase）抑制剂 -
A3635 MRT67307 HClTarget: TBK1|MARK1|NUAK1Summary: SIK/TBK-1/IKKe抑制剂 -
A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂 -
A4302 Rosiglitazone maleate中文名: 马来酸罗格列酮Target: Insulin and Insulin-like ReceptorsSummary: PPARγ激动剂，有效的胰岛素敏化剂